McDermott to Host Life Sciences event for BIBA
Ryan McDermott, Managing Director of McDermott & Thomas Associates, will be hosting an event at the Boston Irish Business Association (BIBA) on September 9, 2009. This will be BIBA’s kicks off event for its 2009-2010 Evening Networking Season as well as its launch under its new name. McDermott was recently installed on the board of BIBA and has taken an active role in developing future programs as the Chair of the programs committee.
The theme for the evening will be Life Sciences and our guest speaker will be Frank Reynolds, CEO of Invivo Therapeutics, an emerging Medical Device Company focused on paralysis treatment. InVivo has received numerous awards including $500,000 from the Massachusetts Life Sciences Center as part of MLSC’s Accelerator Loan Program.
To read more about the details of the event and to RSVP, please click here:
http://events.linkedin.com/ICCUSA-Evening-Meeting-Evening-Life/pub/98808
About BIBA: BIBA is a non-profit membership organization with a clear focus on business and the development of economic, commercial and educational links between the United States the island of Ireland and Europe. Our membership consists of a broad cross-section of businesspersons, professionals and entrepreneurs from Ireland, Northern Ireland and the U.S. BIBA is managed by a board of Directors selected from the membership of the group.
About Invivo Therapeutics: InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on combining polymers and stem cells to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard’s Brigham and Women’s Hospital.
